Deltex Medical Group Share Forecast, Price & News

GBX 1.56
-0.19 (-10.86 %)
(As of 07/27/2021 09:09 AM ET)
Today's Range
50-Day Range
52-Week Range
Volume200,000 shs
Average Volume599,026 shs
Market Capitalization£9.01 million
P/E RatioN/A
Dividend YieldN/A
30 days | 90 days | 365 days | Advanced Chart
Receive DEMG News and Ratings via Email

Sign-up to receive the latest news and ratings for Deltex Medical Group and its competitors with MarketBeat's FREE daily newsletter.

About Deltex Medical Group

Deltex Medical Group plc, together with its subsidiaries, manufactures, markets, and sells oesophageal doppler haemodynamic monitoring systems under the TrueVue name in the United Kingdom, the United States, Spain, Canada, and internationally. It offers Doppler Probes that is used to measure a patient's blood flow and fluid status directly from the descending aorta during surgery and critical care; Loops plots aortic blood flow velocity and aortic blood pressure monitoring throughout every heartbeat; High Definition Impedance Cardiography, a non-invasive cardiac function and fluid status monitoring system for awake patients; and PressureWave, a pulse pressure wave algorithm for deriving haemodynamic parameters. The company's products are used in Covid-19 critical care; sepsis; major abdominal, laparoscopic, and spinal surgeries; cardiac, trauma, and transplant procedures; and post-operative acute kidney injury monitoring. Deltex Medical Group plc was incorporated in 2000 and is headquartered in Chichester, the United Kingdom.


See More Headlines

Industry, Sector and Symbol

Sales & Book Value






Overall MarketRank

0.48 out of 5 stars

Analyst Opinion: 0.0Community Rank: 2.4Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.0 5 -4 -3 -2 -1 -
speech bubbles
speech bubbles

Deltex Medical Group (LON:DEMG) Frequently Asked Questions

What stocks does MarketBeat like better than Deltex Medical Group?

Wall Street analysts have given Deltex Medical Group a "N/A" rating, but there may be better buying opportunities in the stock market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new stock ideas, but Deltex Medical Group wasn't one of them. MarketBeat thinks these five companies may be even better buys.
View MarketBeat's top stock picks here.

When is Deltex Medical Group's next earnings date?

Deltex Medical Group is scheduled to release its next quarterly earnings announcement on Monday, September 20th 2021.
View our earnings forecast for Deltex Medical Group

How were Deltex Medical Group's earnings last quarter?

Deltex Medical Group plc (LON:DEMG) announced its quarterly earnings results on Monday, September, 21st. The company reported ($0.11) earnings per share (EPS) for the quarter.
View Deltex Medical Group's earnings history

How has Deltex Medical Group's stock price been impacted by COVID-19 (Coronavirus)?

Deltex Medical Group's stock was trading at GBX 1.15 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization (WHO). Since then, DEMG stock has increased by 35.7% and is now trading at GBX 1.56.
View which stocks have been most impacted by COVID-19

Who are Deltex Medical Group's key executives?

Deltex Medical Group's management team includes the following people:
  • Mr. Andrew Jonathan Mears, CEO & Director (Age 52, Pay $183.12k)
  • Ms. Natalie Emilia Wettler, Group Fin. Director (Age 38)
  • Ms. Marion Lee, HR Director

Who are some of Deltex Medical Group's key competitors?

What other stocks do shareholders of Deltex Medical Group own?

Based on aggregate information from My MarketBeat watchlists, some companies that other Deltex Medical Group investors own include Indivior (INDV), Nanoco Group (NANO), Ocado Group (OCDO), Tullow Oil (TLW), Bigblu Broadband (BBB), Actua (ACTA), Directa Plus (DCTA), Futura Medical (FUM), Ilika (IKA) and Lakehouse (LAKE).

What is Deltex Medical Group's stock symbol?

Deltex Medical Group trades on the London Stock Exchange (LON) under the ticker symbol "DEMG."

How do I buy shares of Deltex Medical Group?

Shares of DEMG and other U.K. stocks can be purchased through online brokerage accounts that support trading on the London Stock Exchange (LSX). Some U.K. companies can be purchased through major U.S. brokerages in the form of American Depository Receipts (ADRs), which are placeholder equities held in a trust by a bank that represent shares of a foreign stock.
Compare Top Brokerages Here.

What is Deltex Medical Group's stock price today?

One share of DEMG stock can currently be purchased for approximately GBX 1.56.

How much money does Deltex Medical Group make?

Deltex Medical Group has a market capitalization of £9.01 million and generates £2.40 million in revenue each year.

How many employees does Deltex Medical Group have?

Deltex Medical Group employs 52 workers across the globe.

What is Deltex Medical Group's official website?

The official website for Deltex Medical Group is www.deltexmedical.com.

Where are Deltex Medical Group's headquarters?

Deltex Medical Group is headquartered at Terminus Road, CHICHESTER, PO19 8TX, United Kingdom.

How can I contact Deltex Medical Group?

Deltex Medical Group's mailing address is Terminus Road, CHICHESTER, PO19 8TX, United Kingdom. The company can be reached via phone at +44-1243-774837.

This page was last updated on 7/27/2021 by MarketBeat.com Staff
MarketBeat - Stock Market News and Research Tools logo

MarketBeat empowers individual investors to make better trading decisions by providing real-time financial data and objective market analysis. Whether you’re looking for analyst ratings, corporate buybacks, dividends, earnings, economic reports, financials, insider trades, IPOs, SEC filings or stock splits, MarketBeat has the objective information you need to analyze any stock. Learn more about MarketBeat.

MarketBeat is accredited by the Better Business Bureau

© American Consumer News, LLC dba MarketBeat® 2010-2021. All rights reserved.
326 E 8th St #105, Sioux Falls, SD 57103 | U.S. Based Support Team at [email protected] | (844) 978-6257
MarketBeat does not provide personalized financial advice and does not issue recommendations or offers to buy stock or sell any security.

Our Accessibility Statement | Terms of Service | Do Not Sell My Information

© 2021 Market data provided is at least 10-minutes delayed and hosted by Barchart Solutions. Information is provided 'as-is' and solely for informational purposes, not for trading purposes or advice, and is delayed. To see all exchange delays and terms of use please see disclaimer. Fundamental company data provided by Zacks Investment Research.